Cue Health Inc.
DelistedCIK 1628945fmd_1ECWPT1DV7GJ9ZCSXA7T32WASNManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2023, 15 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Total revenues | 7 | 23 | 618 | 483 | 71 |
| Research and development | 21 | 28 | 43 | 171 | 151 |
| Selling, general and administrative | 6 | 25 | 109 | 186 | 90 |
| Operating income | (21) | (45) | 190 | (206) | (395) |
| Interest expense | – | – | 10 | 1 | 1 |
| Other non-operating income (expense) | 0 | 0 | 0 | (1) | 0 |
| Income before taxes | (21) | (47) | 119 | (204) | (369) |
| Income tax expense | 0 | 0 | 33 | (10) | 5 |
| Net income from continuing operations | (21) | (47) | 86 | (194) | (373) |
| Net income | (21) | (47) | 86 | (194) | (373) |
| Net income to common shareholders | (21) | (47) | 33 | (194) | (373) |